Prelude Therapeutics Inc (PRLD) Insider Trading
0 insider purchases in the last 7 days
No open market insider purchases at Prelude Therapeutics Inc in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track PRLD on your watchlist.
Start for FreeAbout Prelude Therapeutics Inc Insider Trading
2 insiders at Prelude Therapeutics Inc (PRLD) have purchased stock in the past 90 days, totaling $25.0M across 4 transactions (5,630,630 shares).
The most recent purchase was by Director Bonita David P on April 21, 2026 — a $7.5M buy of 1,689,189 shares at $4.44, bringing his total holdings to 11,808,945 shares.
Insiders who purchased: Bonita David P (Director, 2 buys totaling $12.5M); ORBIMED ADVISORS LLC (Director, 2 buys totaling $12.5M).
This insider buying is notable given that PRLD had no recorded open market purchases in the nine months before that.
Track PRLD insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.